- Home
- CCRN vs ARVN Comparison
CCRN vs ARVN Comparison
Compare CCRN & ARVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCRN
- ARVN
- Stock Information
- Founded
- CCRN 1986
- ARVN 2015
- Country
- CCRN United States
- ARVN United States
- Employees
- CCRN N/A
- ARVN N/A
- Industry
- CCRN Professional Services
- ARVN Biotechnology: Pharmaceutical Preparations
- Sector
- CCRN Consumer Discretionary
- ARVN Health Care
- Exchange
- CCRN Nasdaq
- ARVN Nasdaq
- Market Cap
- CCRN 447.2M
- ARVN 456.2M
- IPO Year
- CCRN N/A
- ARVN 2018
- Fundamental
- Price
- CCRN $12.20
- ARVN $7.62
- Analyst Decision
- CCRN Hold
- ARVN Buy
- Analyst Count
- CCRN 5
- ARVN 22
- Target Price
- CCRN $17.93
- ARVN $20.21
- AVG Volume (30 Days)
- CCRN 347.9K
- ARVN 1.4M
- Earning Date
- CCRN 11-05-2025
- ARVN 10-29-2025
- Dividend Yield
- CCRN N/A
- ARVN N/A
- EPS Growth
- CCRN N/A
- ARVN N/A
- EPS
- CCRN N/A
- ARVN N/A
- Revenue
- CCRN $1,192,539,000.00
- ARVN $372,800,000.00
- Revenue This Year
- CCRN N/A
- ARVN $4.87
- Revenue Next Year
- CCRN N/A
- ARVN N/A
- P/E Ratio
- CCRN N/A
- ARVN N/A
- Revenue Growth
- CCRN N/A
- ARVN 299.57
- 52 Week Low
- CCRN $9.58
- ARVN $5.90
- 52 Week High
- CCRN $18.33
- ARVN $29.61
- Technical
- Relative Strength Index (RSI)
- CCRN 37.17
- ARVN 50.66
- Support Level
- CCRN $11.09
- ARVN $7.58
- Resistance Level
- CCRN $14.30
- ARVN $8.23
- Average True Range (ATR)
- CCRN 0.65
- ARVN 0.38
- MACD
- CCRN -0.11
- ARVN 0.01
- Stochastic Oscillator
- CCRN 36.76
- ARVN 35.11
About CCRN Cross Country Healthcare Inc. $0.0001 Par Value
Cross Country Healthcare Inc is a provider of total talent management services, including strategic workforce solutions, contingent staffing, permanent placement and consultative services for healthcare customers. The company operates in two business segments: the nurse and allied staffing segment, which generates a vast majority of revenue, offers temporary and permanent placements of travel and local nurses and allied professionals, and other outsourcing services.: the Physician Staffing segment provides licensed practitioners across a broad array of specialties, as well as certified registered nurse anesthetists (CRNAs), nurse practitioners (NPs), and physician assistants (PAs) on temporary assignments. The company earns majority of its revenue from the United States.
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.